This has really caught everyone with their pants down.
In the long history of nations navigating the tension between sovereignty and collective responsibility, the United States has taken a sudden and consequential step inward. By executive order, the Trump administration directed the CDC to immediately sever all working ties with the World Health Organization — not through the measured process that international law and domestic governance require, but overnight, by memo. The move disrupts decades of collaborative disease surveillance at a moment when Marburg, mpox, and bird flu are actively testing the world's early-warning systems, raising a quiet but urgent question: when a nation withdraws from the shared work of watching for danger, who bears the cost of what goes unseen?
- A single memo sent Sunday night ordered every CDC employee engaged with WHO — across working groups, advisory boards, and cooperative agreements — to stop immediately, catching global health officials completely off guard.
- Active outbreak investigations into Marburg virus and mpox in Africa are now stalled, and the international bird flu monitoring network has lost one of its most critical contributors.
- Health experts warn this is not a slow, negotiated exit — it is an abrupt severance of a two-way intelligence system that has protected Americans and vulnerable populations worldwide for decades.
- The formal withdrawal process legally requires Congressional approval and a one-year notice period, leaving open the possibility of reversal — but the operational damage is accumulating in real time.
- Federal health agencies have simultaneously been ordered to restrict public communications, deepening the silence around an already opaque and rapidly evolving situation.
On Sunday night, the CDC sent a memo through its ranks with a stark instruction: all collaboration with the World Health Organization was to stop immediately. Distributed by senior CDC official John Nkengasong, the directive covered every channel of engagement — technical working groups, advisory boards, cooperative agreements, even visits to WHO offices, whether in person or online. Staff were told to stand down and await further guidance.
The order followed President Trump's executive action initiating U.S. withdrawal from WHO, but it moved far faster than anyone had expected. Formal departure requires Congressional approval and a one-year notice period, and the U.S. still carries financial obligations for the current fiscal year. None of that procedural architecture slowed the memo. It was immediate and total.
The consequences were concrete and swift. Investigations into Marburg virus and mpox outbreaks across Africa were left in limbo. Global surveillance networks tracking bird flu through U.S. livestock — efforts that depend on shared data and coordinated response — lost their American anchor. Dr. Jeffrey Klausner of the University of Southern California, who works with WHO on sexually transmitted infections, learned of the halt secondhand. "People thought there would be a slow withdrawal," he said. "This has really caught everyone with their pants down."
The relationship between the CDC and WHO has long functioned as a two-way exchange — early warnings, diagnostic tools, outbreak intelligence — that benefits both American public health and the broader world. That exchange is now frozen. Federal agencies were also directed to restrict most public communications through at least the end of January, adding another layer of opacity to an already uncertain moment.
Whether Congress will intervene, and whether the operational machinery can be restored before meaningful ground is lost, remains an open question. What is already clear is that the surveillance infrastructure built over decades has gone dark at the American end — and outbreaks do not pause to wait for policy to catch up.
On Sunday night, the Centers for Disease Control and Prevention sent word through its ranks: stop talking to the World Health Organization, effective immediately. John Nkengasong, a senior CDC official, distributed a memo to agency leadership with the instruction that all staff engaged with WHO—through technical working groups, coordinating centers, advisory boards, cooperative agreements, or any other channel—must cease their work and await further direction. CDC employees were also barred from visiting WHO offices. The order applied whether the collaboration happened in person or online.
This was not the slow, bureaucratic unwinding that global health experts had anticipated. President Trump had signed an executive order the previous week initiating the U.S. withdrawal from WHO, but that process was supposed to unfold over time. Formal departure requires Congressional approval and a one-year notice period. The U.S. also has financial obligations to meet for the current fiscal year. But the memo from Nkengasong bypassed all of that. It was immediate. It was total.
The abruptness caught the international health community off guard. Experts pointed to concrete consequences already unfolding: investigations into Marburg virus and mpox outbreaks across Africa would stall. Global disease surveillance networks that depend on American participation would lose a critical node. Health authorities worldwide were simultaneously tracking bird flu spreading through U.S. livestock—a situation that benefits from coordinated information sharing. That coordination was now severed.
Dr. Jeffrey Klausner, a public health researcher at the University of Southern California who works with WHO on sexually transmitted infections, learned of the halt from someone inside the CDC. "People thought there would be a slow withdrawal," he said. "This has really caught everyone with their pants down." The sudden stoppage represented a fundamental break in how global disease response operates. WHO and American health officials have long functioned as a two-way street, each side learning from the other's expertise, each gaining early warning of emerging threats. The U.S. benefits from access to new diagnostic tests and treatments developed elsewhere. It gains intelligence about outbreaks brewing in distant regions—information that can protect Americans both abroad and at home. That exchange was now frozen.
The Trump administration had also directed federal health agencies to halt most public communications through at least the end of January, adding another layer of silence to an already opaque moment. A U.S. health official, speaking anonymously because they were not authorized to discuss the memo, confirmed the stoppage was real. The Department of Health and Human Services did not immediately respond to requests for comment. A WHO spokesperson deferred all questions back to U.S. officials.
What happens next remains unclear. The formal withdrawal process could take months or longer, and Congress could theoretically block it. But the operational damage is already occurring. Outbreak investigations are paused. Information flows have stopped. The machinery of global disease surveillance, built over decades and tested repeatedly during pandemics, has been switched off at the American end. The question now is whether it can be switched back on, and how much ground will be lost in the meantime.
Citações Notáveis
People thought there would be a slow withdrawal. This has really caught everyone with their pants down.— Dr. Jeffrey Klausner, University of Southern California public health expert
Stopping communications and meetings with WHO is a big problem. WHO and U.S. health officials benefit from each other's expertise.— Dr. Jeffrey Klausner
A Conversa do Hearth Outra perspectiva sobre a história
Why would the CDC stop immediately if the formal withdrawal takes a year?
Because the administration wanted to signal something beyond policy—a complete break, not a gradual one. The memo made it clear this wasn't negotiable or temporary.
What's actually lost when the CDC stops talking to WHO?
Real-time disease intelligence. If mpox flares up in Central Africa, WHO sees it first, shares it with partners. The U.S. loses that early warning. You also lose the chance to learn about new treatments or diagnostic tools being tested elsewhere.
Could this actually harm Americans?
Yes. A bird flu outbreak in Asia that WHO tracks could reach U.S. shores. Without that partnership, the CDC is flying blind. You're also losing the ability to send expertise abroad to help contain outbreaks before they spread.
Is there any way this gets reversed?
Congress has to approve the withdrawal formally, and there's a one-year notice requirement. So technically, yes. But the damage to relationships and trust happens immediately. Even if it's reversed, you've signaled to global partners that the U.S. can't be relied on.
What did health experts expect instead?
A phased withdrawal over months. Time to transition responsibilities, wind down projects, hand off data. This was a hard stop. That's what shocked people.